Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00241384 · ClinicalTrials.gov registry record · Phase 3
Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer
A Phase 3 study of Prostate Cancer, sponsored by Schiffler Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 396
- Enrollment target
- 2
- Study locations
NCT00241384: Completed Phase 3 study of Prostate Cancer, sponsored by Schiffler Cancer Center.
NCT00241384 is a Phase 3 study of Prostate Cancer that has completed, run by Schiffler Cancer Center. The registered enrollment target is 396 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (35% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00241384, a Phase 3 study of Prostate Cancer, has completed, sponsored by Schiffler Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 396 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary purpose of this study is to evaluate two treatment regimens for prostate cancer, prostate implant with 20 Gy of external beam radiation therapy versus prostate implant with 0 Gy of external beam radiation therapy. Patients diagnosed with intermediate risk prostate cancer between the ages of 40 and 80 who have chosen brachytherapy with or without external beam radiation therapy as their intended treatment will be eligible and will be offered participation.
Conditions Studied
Interventions
- PROCEDURE External beam radiation
- PROCEDURE Pd-103
Study Locations (2)
Washington
- Veterans Administration Puget Sound Health Care System - Seattle
West Virginia
- Schiffler Cancer Center - Wheeling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 396 participants |
| Start Date | 2005-01 |
| Est. Completion | 2015-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00241384
The ClinicalTrials.gov registry entry for NCT00241384 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 396 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (35% lower). The listed sponsor is Schiffler Cancer Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which External beam radiation is the first listed.
NCT00241384 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Washington, West Virginia.
Frequently Asked Questions
What is clinical trial NCT00241384 about?
NCT00241384 is a clinical study titled "Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer". The primary purpose of this study is to evaluate two treatment regimens for prostate cancer, prostate implant with 20 Gy of external beam radiation therapy versus prostate implant with 0 Gy of external beam radiation therapy. Patients diagnosed with intermediate risk prostate cancer between the ages...
What is the current status of trial NCT00241384?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 396 participants. The study started on 2005-01. Estimated completion is 2015-11.
What conditions does trial NCT00241384 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT00241384?
The interventions under investigation include: External beam radiation (PROCEDURE), Pd-103 (PROCEDURE).
Who is sponsoring clinical trial NCT00241384?
This trial is sponsored by Schiffler Cancer Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00241384 being conducted?
This trial has 2 study locations across Washington, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
RECRUITING · Phase 3
-
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
RECRUITING · Phase 3
-
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
RECRUITING · Phase 3
-
Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)
RECRUITING · Phase 3
-
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
RECRUITING · Phase 3
-
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
RECRUITING · Phase 3
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.